Summit Therapeutics (SMMT) Return on Sales (2016 - 2025)
Historic Return on Sales for Summit Therapeutics (SMMT) over the last 9 years, with Q3 2025 value amounting to 3.5231079858176e16%.
- Summit Therapeutics' Return on Sales fell 3.523107985817601e20% to 3.5231079858176e16% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.5231079858176e16%, marking a year-over-year decrease of 3.523107985817601e20%. This contributed to the annual value of 111.75% for FY2022, which is 627700.0% down from last year.
- According to the latest figures from Q3 2025, Summit Therapeutics' Return on Sales is 3.5231079858176e16%, which was down 3.523107985817601e20% from 6.789001117696e16% recorded in Q2 2025.
- Over the past 5 years, Summit Therapeutics' Return on Sales peaked at 40.77% during Q1 2025, and registered a low of 6.789001117696e16% during Q2 2025.
- Moreover, its 4-year median value for Return on Sales was 169.27% (2022), whereas its average is 1.2375142245025652e16%.
- Per our database at Business Quant, Summit Therapeutics' Return on Sales soared by 2000000000bps in 2024 and then tumbled by 2000000000bps in 2025.
- Over the past 4 years, Summit Therapeutics' Return on Sales (Quarter) stood at 169.27% in 2022, then plummeted by 2000000000bps to 3.359079111969545e16% in 2023, then surged by 100bps to 20.32% in 2024, then tumbled by 2000000000bps to 3.5231079858176e16% in 2025.
- Its last three reported values are 3.5231079858176e16% in Q3 2025, 6.789001117696e16% for Q2 2025, and 40.77% during Q1 2025.